Types and severity of medication errors in Iran; a review of the current literature

Ava Mansouri1, Alireza Ahmadvand, Molouk Hadjibabaie

  • 1Faculty of Pharmacy, and Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran. hajibaba@tums.ac.ir.

Insights

Medication errors (ME) are a major patient safety concern. This review highlights significant variations in ME prevalence in Iran, likely due to study quality issues, with administration errors being most common.

Area of Science:

  • Healthcare Quality and Safety
  • Clinical Pharmacy
  • Patient Safety Research

Background:

  • Medication errors (ME) are a leading cause of preventable adverse drug events, impacting patient safety.
  • Reliable ME prevalence data is crucial for healthcare system evaluation, but studies from developing nations like Iran are often inadequate.
  • Existing research presents wide variations in ME estimations, decreasing reliability.

Purpose of the Study:

  • To systematically review and analyze existing literature on medication errors in Iran.
  • To clarify the current status and identify patterns of ME across different drug delivery stages.
  • To assess the quality and identify research gaps in ME studies conducted in Iran.

Main Methods:

  • A comprehensive literature search was conducted across major international (Scopus, Web of Science, PubMed, CINAHL, EBSCOHOST) and Persian (IranMedex, SID) databases up to October 2012.
  • Included studies focused on prescription, transcription, dispensing, and administration errors in adult and pediatric populations.
  • Data on ME types, definitions, and severity were extracted and classified by drug delivery stages.

Main Results:

  • Eighteen studies (11 Persian, 7 English), all cross-sectional and hospital-based, were included.
  • Nursing staff and students were the most studied populations.
  • Administration errors showed the highest prevalence (14.3%-70.0%), followed by prescribing (29.8%-47.8%), transcribing (10.0%-51.8%), and dispensing errors (11.3%-33.6%).
  • Most studies lacked overall ME frequency reporting and focused on specific error types.
  • Only three studies reported on ME severity, and no follow-up or repeated studies were identified.

Conclusions:

  • Medication error research in Iran is nascent, characterized by a limited number of publications and short study durations.
  • The wide range of reported ME prevalence suggests potential issues with study quality, including diverse definitions, methodologies, and populations.
  • Further research is recommended to investigate ME sources, address underreporting, and develop effective preventive strategies in Iran.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...